Latest updates

Latest data shows some companies are not excelling in innovation

Latest Data Shows Despite Large R&D Investments, Pharmaceutical and Medical Device Companies Are Not Excelling in Innovation

On May 11, Innovaro Strategos and wRating released their latest quarterly Strategos/wRatings Innovation Index. This quarter, the report assessed innovation performance of pharmaceutical and medical device companies.

A review of our top 10 ranked pharmaceutical and medical device companies (see chart below) shows a collection of companies that have developed and continue to develop wondrous drugs and medical devices, saving and improving the quality of millions of lives. These companies delivered treatments for HIV, heart failure, hepatitis C, Alzheimer, Huntingtons, cancer and other complex medical conditions, and they are deploying advanced technologies, such as antisense, nano-particle and gene therapies to aid discovery and enhance treatment delivery. These are indeed some of the best inventors in the world. Unfortunately, their innovation performance lags significantly behind other industries that have appeared in the Strategos/wRatings Innovation Index, highlighting the point that innovation is more than technology invention.

Click here to download the report. (http://www.strategos.com)

UTEK Europe Ltd changes name to Innovaro Europe Ltd

As of Tuesday 16th March 2010, UTEK Europe Ltd will do business as Innovaro Europe Ltd.

Over the past few years, our mother company UTEK Corporation of Tampa, Florida has acquired several complimentary organizations that have allowed us to expand our innovation and intellectual property offerings to clients. Bringing this collection of businesses together makes us the only public company to offer a comprehensive end-to-end innovation solution. We have made it a priority to position and align the company to most clearly present our value to clients, potential clients, investors and the public. Doing so under one brand will allow us to present a cohesiveness to our clients and showcase our greater value to the market.

Effective today, we will organize the Company into three business groups, all working under the Innovaro brand:

Insights & Research — Futures trend analysis, research, information services and more;

Strategic Services — Led by Strategos, our leading consulting businesses;

Technology Marketplaces — our online platforms, including Pharmalicensing and Medical Device Licensing, leading partnering, global licensing and technology transfer services.

As we looked to consolidate brands we chose Innovaro, a name within our current portfolio which we felt could best represent the entire company, one that could scale and grow with the business. We believe Innovaro carries with it inherent relevancy and also the flexibility we need to raise awareness and visibility of our Company within the industry and, importantly, with our clients and prospective clients.

Our clients look to us to navigate, with them, through the complexities of the entire innovation ecosystem. Under this new structure, we have the potential to extend and deepen our relationships with clients along the entire innovation value-chain; developing compelling strategies; identifying, designing and modeling breakthrough ideas; and accelerating those ideas into the market successfully. Leading companies trust us to create profitable growth, new revenue streams, enduring capabilities and lasting value through innovation.

Please be assured that this change of name will in no way affect the day-to-day benefits we offer to you as a user of the Pharmalicensing/Medical Device Licensing services. In fact through the broad Innovaro services we will be able to offer to you a more comprehensive portfolio of services for the betterment of your partnering activities.

"Successfully Grow Your Medtech Business via Financing, Acquisition, and Partnering"

IN3 East

June 9-11, 2010 — Boston

IN3 East specifically partners a global audience of VCs, top investors, and corporate acquirers with early-/mid-/late-stage, medical technology start-ups and revolutionary innovators. Whether you are an innovator looking for the opportunity to communicate your technology, a large device company or health care investment firm in search of key opportunities, or a service provider seeking to support innovators with their needs, IN3 Conferences are the industry's premier platform for successful dealmaking and key syndication opportunities! Learn more.

MedicalDeviceLicensing.com announces a new pricing model

Innovaro Europe, is pleased to announce a new pricing model known as 'Pay-per-Click' Established to further expand listed opportunities and remove market barriers, this new model is effective from Jan 13th 2010.

The newly introduced Pay-per-Click pricing will create further market efficiencies for Innovaro Medical Device Licensing and will provide additional opportunities for buyers and sellers to access the platform, thereby creating a larger online IP marketplace.

"In 2009, we spent considerable effort listening to our clients on how we might serve the marketplace better. I believe this pricing change will further extend our lead and continue to make our marketplace the most efficient and highly trafficked online licensing platform in the medical device sector." Mark McBride, Managing Director of Innovaro Pharmalicensing / Innovaro Medical Device Licensing continues, "Our Pay-per-Click option is intended to remove pricing barriers for users of our service, increasing our base of potential clients. We continue to take as much risk as possible out of our clients' partner search process, and offer our visitors more opportunities to meet their medical device requirements."

All new clients will be eligible for the pricing structure, which will enable companies to post their profile and only pay for qualified traffic. Pay-per-Click clients will pay only for the partnering opportunities or potential partner click-throughs they receive. The Company plans to expand the new pricing model to additional licensing platforms which are due to be launched in 2010.

For more information please visit Pay-per-Click page.

Providing you with a prospect list of partners

As a developer of an innovative product or technology in the pharmaceutical industry it is inevitable that one day you will require the services of a partner.

The Partnering Search service from Innovaro Medical Device Licensing is designed to move the workload associated with finding partners from you over to us.

Following your instructions and based entirely on your criteria, the Partnering Search Team at Innovaro Medical Device Licensing will actively search for partners on your behalf and provide you with a qualified list of target companies.

•  Find out more
•  Contact our team to arrange your partner search

Our Products

Deal Negotiation

Innovaro Medical Device Licensing now offers expert support to assist and guide you through the entire deal negotiation process.

From the moment you select your partner, Innovaro Medical Device Licensing can help you with initial discussions, preparation of introductory material and suitable deal structure implementation, amongst other things.

Find out more about Deal Negotiation services

Get the Flash Player to see this rotator.